The present invention provides methods for manufacturing neuraminic acid derivatives.[Means for solution]Methods for manufacturing compounds represented by the formula (I) :[wherein R1 represents a C1-C19 alkyl group], or a pharmacologically acceptable salt thereof, using N-acetylneuraminic acid dihydrate as a starting raw material are provided.